Kimberly-Clark will buy Tylenol maker Kenvue for more than $40 billion in a historic deal that comes as the smaller company ...
If you’re tired of the seemingly endless parade of AI cloud deals, better get comfortable with them: They’re not going away ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する